Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence (Q31148416)
scientific article
Language:
Current Data About Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence
(P31) (Q13442814)
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

(P304) 779-787
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

(P407) (Q1860)

(P433) 10
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

(P478) 70
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

(P577) Saturday, March 1, 2008
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

(P921) (Q413299)
(P887)

(P1433) (Q1161692)
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

(P1476) "Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence" (language: en)
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

(P2093) A D Norden
(P1545) 1
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

G S Young
(P1545) 2
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

K Setayesh
(P1545) 3
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

A Muzikansky
(P1545) 4
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

R Klufas
(P1545) 5
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

G L Ross
(P1545) 6
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

A S Ciampa
(P1545) 7
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

L G Ebbeling
(P1545) 8
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

B Levy
(P1545) 9
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

J Drappatz
(P1545) 10
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

S Kesari
(P1545) 11
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017

P Y Wen
(P1545) 12
(P248)
(P698) 18316689
(P813) Thursday, June 29, 2017